Satomi Watanabe Masayuki Takeda Tomoyuki Otani Takeshi Yoshida Kazuko Sakai Elizabeth Olek S Michael Rothenberg Jennifer Kherani Pearl P French Kazuto Nishio Akihiko Ito Kazuhiko Nakagawa
10.1200/PO.20.00282
JCO Precis Oncol
2021 Jan 11;5:PO.20.00282.
CC BY
https://pubmed.ncbi.nlm.nih.gov/34036231/
Breast Neoplasms / drug therapy Proto-Oncogene Proteins c-ret / antagonists & inhibitors Pyrazoles / therapeutic use Pyridines / therapeutic use
Breast Neoplasms / drug therapy Proto-Oncogene Proteins c-ret / antagonists & inhibitors Pyrazoles / therapeutic use Pyridines / therapeutic use Case Reports Research Support, Non-U.S. Gov't Breast Neoplasms / chemistry Female Humans Middle Aged Proto-Oncogene Proteins c-ret / analysis Treatment Outcome Pyrazoles Pyridines selpercatinib Proto-Oncogene Proteins c-ret RET protein, human
PMC8140803
34036231
Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer
2021